Abnova (Taiwan) Profit Margin

The latest profit margin for 4133.TW is 12.99% as of June 2026. That compares with -1.82% in the prior-year period — up 814.1% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Abnova (Taiwan)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4133.TW's profit margin moved from -1.82% to 12.99% — a 814.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abnova (Taiwan)'s valuation or profitability profile.

Against Healthcare companies, 4133.TW currently prints 12.99% for profit margin, while the sector average sits near 9.48%. That is roughly 37.0% above the sector mean. Large gaps often invite a closer look at Abnova (Taiwan)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Abnova (Taiwan) converts resources into returns. At 12.99%, 4133.TW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.82% in the prior-year period — up 814.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4133.TW's profit margin (12.99%), review year-over-year change from -1.82%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.